{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:27:01Z","timestamp":1793744821808,"version":"4.6.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671070"],"award-info":[{"award-number":["81671070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772454"],"award-info":[{"award-number":["81772454"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Soluble beta-amyloid (A\u03b2) can be cleared from the brain through various mechanisms including enzymatic degradation, glial cell phagocytosis, transport across the blood-brain barrier, and glymphatic clearance. However, the relative contribution of each clearance system and their compensatory effects in delaying the pathological process of Alzheimer\u2019s disease (AD) are currently unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fluorescent trace, immunofluorescence, and Western blot analyses were performed to compare glymphatic clearance ability and A\u03b2 accumulation among 3-month-old APP695\/PS1-dE9 transgenic (APP\/PS1) mice, wild-type mice, aquaporin 4 knock out (AQP4\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      ) mice, and AQP4\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/APP\/PS1 mice. The consequence of selectively eliminating microglial cells, or downregulating apolipoprotein E (apoE) expression, on A\u03b2 burden, was also investigated in the frontal cortex of AQP4\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/APP\/PS1 mice and APP\/PS1 mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AQP4 deletion in APP\/PS1 mice significantly exaggerated glymphatic clearance dysfunction, and intraneuronal accumulation of A\u03b2 and apoE, although it did not lead to A\u03b2 plaque deposition. Notably, microglia, but not astrocytes, increased activation and phagocytosis of A\u03b2 in the cerebral cortex of AQP4\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/APP\/PS1 mice, compared with APP\/PS1 mice. Selectively eliminating microglia in the frontal cortex via local injection of clodronate liposomes resulted in deposition of A\u03b2 plaques in AQP4\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/APP\/PS1 mice, but not APP\/PS1 mice. Moreover, knockdown of apoE reduced intraneuronal A\u03b2 levels in both APP\/PS1 mice and AQP4\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/APP\/PS1 mice, indicating an inhibitory effect of apoE on A\u03b2 clearance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The above results suggest that the glymphatic system mediated A\u03b2 and apoE clearance and microglia mediated A\u03b2 degradation synergistically prevent A\u03b2 plague formation in the early stages of the AD mouse model. Protecting one or both of them might be beneficial to delaying the onset of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-020-00688-1","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T10:02:56Z","timestamp":1601632976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer\u2019s disease mouse model with suppression of glymphatic clearance"],"prefix":"10.1186","volume":"12","author":[{"given":"Weixi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-9102","authenticated-orcid":false,"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"issue":"4","key":"688_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer\u2019s disease. Cell. 2016;164(4):603\u201315.","journal-title":"Cell."},{"issue":"6","key":"688_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608.","journal-title":"EMBO Mol Med"},{"issue":"7","key":"688_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/77397","volume":"6","author":"BV Zlokovic","year":"2000","unstructured":"Zlokovic BV, Yamada S, Holtzman D, Ghiso J, Frangione B. Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat Med. 2000;6(7):718\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"688_CR4","first-page":"605","volume":"43","author":"RE Tanzi","year":"2004","unstructured":"Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer\u2019s Abeta peptide: the many roads to perdition. Neuron. 2004;43(5):605\u20138.","journal-title":"Neuron."},{"issue":"6012","key":"688_CR5","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330(6012):1774.","journal-title":"Science."},{"issue":"8","key":"688_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370.","journal-title":"Nat Rev Neurol"},{"issue":"15","key":"688_CR7","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"CC Liu","year":"2017","unstructured":"Liu CC, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, et al. Astrocytic LRP1 mediates brain A\u03b2 clearance and impacts amyloid deposition. J Neurosci. 2017;37(15):4023\u201331.","journal-title":"J Neurosci"},{"issue":"12","key":"688_CR8","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","volume":"74","author":"L Zuroff","year":"2017","unstructured":"Zuroff L, Daley D, Black KL, Koronyo-Hamaoui M. Clearance of cerebral A\u03b2 in Alzheimer's disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci. 2017;74(12):2167\u2013201.","journal-title":"Cell Mol Life Sci"},{"issue":"147","key":"688_CR9","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4(147):147ra111.","journal-title":"Sci Transl Med"},{"issue":"3","key":"688_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1172\/JCI67677","volume":"123","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Lee H, Yu M, Feng T, Logan J, Nedergaard M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. 2013;123(3):1299\u2013309.","journal-title":"J Clin Invest"},{"issue":"6","key":"688_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76(6):845\u201361.","journal-title":"Ann Neurol"},{"issue":"1","key":"688_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","volume":"74","author":"DM Zeppenfeld","year":"2017","unstructured":"Zeppenfeld DM, Simon M, Haswell JD, D'Abreo D, Murchison C, Quinn JF, et al. Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains. JAMA Neurol. 2017;74(1):91\u20139.","journal-title":"JAMA Neurol"},{"key":"688_CR13","doi-asserted-by":"crossref","unstructured":"Mestre H, Hablitz LM, Xavier AL, Feng W, Zou W, Pu T, et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain. Elife. 2018;7:e40070.","DOI":"10.7554\/eLife.40070"},{"issue":"1","key":"688_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jhep.2018.08.021","volume":"70","author":"A Hadjihambi","year":"2019","unstructured":"Hadjihambi A, Harrison IF, Costas-Rodr\u00edguez M, Vanhaecke F, Arias N, Gallego-Dur\u00e1n R, et al. Impaired brain glymphatic flow in experimental hepatic encephalopathy. J Hepatol. 2019;70(1):40\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"688_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/cns.13194","volume":"26","author":"R Zhang","year":"2020","unstructured":"Zhang R, Liu Y, Chen Y, Li Q, Marshall C, Wu T, et al. Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption. CNS Neurosci Ther. 2020;26(2):228\u201339.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"688_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"S Nielsen","year":"1997","unstructured":"Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci. 1997;17(1):171\u201380.","journal-title":"J Neurosci"},{"key":"688_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","volume":"93","author":"W Peng","year":"2016","unstructured":"Peng W, Achariyar TM, Li B, Liao Y, Mestre H, Hitomi E, et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2016;93:215\u201325.","journal-title":"Neurobiol Dis"},{"issue":"49","key":"688_CR18","doi-asserted-by":"publisher","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","volume":"34","author":"JJ Iliff","year":"2014","unstructured":"Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci. 2014;34(49):16180\u201393.","journal-title":"J Neurosci"},{"key":"688_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","volume":"10","author":"Z Xu","year":"2015","unstructured":"Xu Z, Xiao N, Chen Y, Huang H, Marshall C, Gao J, et al. Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits. Mol Neurodegener. 2015;10:58.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"688_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/jnr.20664","volume":"82","author":"Y Fan","year":"2005","unstructured":"Fan Y, Zhang J, Sun XL, Gao L, Zeng XN, Ding JH, et al. Sex- and region specific alterations of basal amino acid and monoamine metabolism in the brain of aquaporin-4 knockout mice. J Neurosci Res. 2005;82(4):458\u201364.","journal-title":"J Neurosci Res"},{"issue":"9","key":"688_CR21","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1007\/s12035-019-1502-9","volume":"56","author":"X Han","year":"2019","unstructured":"Han X, Li Q, Lan X, El-Mufti L, Ren H, Wang J. Microglial depletion with clodronate liposomes increases proinflammatory cytokine levels, induces astrocyte activation, and damages blood vessel integrity. Mol Neurobiol. 2019;56(9):6184\u201396.","journal-title":"Mol Neurobiol"},{"key":"688_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40478-014-0078-x","volume":"2","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y, Chambers JK, Matsuwaki T, Yamanouchi K, Nishihara M. Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice. Acta Neuropathol Commun. 2014;2:78.","journal-title":"Acta Neuropathol Commun"},{"issue":"49","key":"688_CR23","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu WQ, Walsh DM, Ye Z, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem. 1998;273(49):32730\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"688_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/(SICI)1097-0029(19981001)43:1<24::AID-JEMT4>3.0.CO;2-P","volume":"43","author":"JW Unger","year":"1998","unstructured":"Unger JW. Glial reaction in aging and Alzheimer\u2019s disease. Microsc Res Tech. 1998;43(1):24\u20138.","journal-title":"Microsc Res Tech"},{"issue":"4","key":"688_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","volume":"27","author":"D Kaur","year":"2019","unstructured":"Kaur D, Sharma V, Deshmukh R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer\u2019s disease. Inflammopharmacology. 2019;27(4):663\u201377.","journal-title":"Inflammopharmacology."},{"issue":"1","key":"688_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-4886(02)00049-3","volume":"181","author":"A Kohl","year":"2003","unstructured":"Kohl A, Dehghani F, Korf HW, Hailer NP. The bisphosphonate clodronate depletes microglial cells in excitotoxically injured organotypic hippocampal slice cultures. Exp Neurol. 2003;181(1):1\u201311.","journal-title":"Exp Neurol"},{"key":"688_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1742-2094-9-116","volume":"9","author":"H Kumamaru","year":"2012","unstructured":"Kumamaru H, Saiwai H, Kobayakawa K, Kubota K, van Rooijen N, Inoue K, et al. Liposomal clodronate selectively eliminates microglia from primary astrocyte cultures. J Neuroinflammation. 2012;9:116.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"688_CR28","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G. ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners? Neuron. 2014;81(4):740\u201354.","journal-title":"Neuron."},{"issue":"1","key":"688_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-016-0138-8","volume":"11","author":"TM Achariyar","year":"2016","unstructured":"Achariyar TM, Li B, Peng W, Verghese PB, Shi Y, McConnell E, et al. Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol Neurodegener. 2016;11(1):74.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"688_CR30","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1074\/jbc.M309475200","volume":"279","author":"FM Harris","year":"2004","unstructured":"Harris FM, Tesseur I, Brecht WJ, Xu Q, Mullendorff K, Chang S, et al. Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer\u2019s disease. J Biol Chem. 2004;279(5):3862\u20138.","journal-title":"J Biol Chem"},{"issue":"9","key":"688_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"688_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0197-0186(00)00128-5","volume":"38","author":"A Cedazo-M\u00ednguez","year":"2001","unstructured":"Cedazo-M\u00ednguez A, Wiehager B, Winblad B, H\u00fcttinger M, Cowburn RF. Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE\/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts. Neurochem Int. 2001;38(7):615\u201325.","journal-title":"Neurochem Int"},{"issue":"8","key":"688_CR33","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","volume":"288","author":"LM Tai","year":"2013","unstructured":"Tai LM, Bilousova T, Jungbauer L, Roeske SK, Youmans KL, Yu C, et al. Levels of soluble apolipoprotein E\/amyloid-\u03b2 (A\u03b2) complex are reduced and oligomeric A\u03b2 increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. J Biol Chem. 2013;288(8):5914\u201326.","journal-title":"J Biol Chem"},{"issue":"6","key":"688_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","volume":"17","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001;17(6):157\u201365.","journal-title":"Biomol Eng"},{"issue":"2","key":"688_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2013.12.009","volume":"142","author":"A Bilkei-Gorzo","year":"2014","unstructured":"Bilkei-Gorzo A. Genetic mouse models of brain ageing and Alzheimer\u2019s disease. Pharmacol Ther. 2014;142(2):244\u201357.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"688_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.20101","volume":"55","author":"F Trinchese","year":"2004","unstructured":"Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O. Progressive age-related development of Alzheimer-like pathology in APP\/PS1 mice. Ann Neurol. 2004;55(6):801\u201314.","journal-title":"Ann Neurol"},{"issue":"3","key":"688_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.nbd.2006.05.010","volume":"23","author":"T Van Groen","year":"2006","unstructured":"Van Groen T, Kiliaan AJ, Kadish I. Deposition of mouse amyloid beta in human APP\/PS1 double and single AD model transgenic mice. Neurobiol Dis. 2006;23(3):653\u201362.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"688_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11604-017-0617-z","volume":"35","author":"T Taoka","year":"2017","unstructured":"Taoka T, Masutani Y, Kawai H, Nakane T, Matsuoka K, Yasuno F, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer\u2019s disease cases. Jpn J Radiol. 2017;35(4):172\u20138.","journal-title":"Jpn J Radiol"},{"key":"688_CR39","doi-asserted-by":"crossref","unstructured":"Smith AJ, Yao X, Dix JA, Jin BJ, Verkman AS. Test of the \u2018glymphatic\u2019 hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. Elife. 2017;6:e27679.","DOI":"10.7554\/eLife.27679"},{"issue":"2","key":"688_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1096\/fj.201700999","volume":"32","author":"AJ Smith","year":"2018","unstructured":"Smith AJ, Verkman AS. The \u201cglymphatic\u201d mechanism for solute clearance in Alzheimer\u2019s disease: game changer or unproven speculation? FASEB J. 2018;32(2):543\u201351.","journal-title":"FASEB J"},{"issue":"4","key":"688_CR41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5858\/2001-125-0489-IAAPDO","volume":"125","author":"KA Gyure","year":"2001","unstructured":"Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med. 2001;125(4):489\u201392.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"688_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.neurobiolaging.2005.05.022","volume":"26","author":"GK Gouras","year":"2005","unstructured":"Gouras GK, Almeida CG, Takahashi RH. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer\u2019s disease. Neurobiol Aging. 2005;26(9):1235\u201344.","journal-title":"Neurobiol Aging"},{"issue":"40","key":"688_CR43","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"7","key":"688_CR44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991\u20139.","journal-title":"J Exp Med"},{"issue":"7560","key":"688_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337\u201341.","journal-title":"Nature."},{"issue":"7717","key":"688_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature. 2018;560(7717):185\u201391.","journal-title":"Nature."},{"issue":"2","key":"688_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/bpa.12656","volume":"29","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang Y, Zhao Y, Marshall C, Wu T, Xiao M. Deep cervical lymph node ligation aggravates AD-like pathology of APP\/PS1 mice. Brain Pathol. 2019;29(2):176\u201392.","journal-title":"Brain Pathol"},{"issue":"4","key":"688_CR48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.mcn.2012.02.002","volume":"49","author":"W Yang","year":"2012","unstructured":"Yang W, Wu Q, Yuan C, Gao J, Xiao M, Gu M, et al. Aquaporin-4 mediates astrocyte response to \u03b2-amyloid. Mol Cell Neurosci. 2012;49(4):406\u201314.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"688_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40478-019-0728-0","volume":"7","author":"AJ Smith","year":"2019","unstructured":"Smith AJ, Duan T, Verkman AS. Aquaporin-4 reduces neuropathology in a mouse model of Alzheimer\u2019s disease by remodeling peri-plaque astrocyte structure. Acta Neuropathol Commun. 2019;7(1):74.","journal-title":"Acta Neuropathol Commun."},{"issue":"1","key":"688_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-016-0099-y","volume":"11","author":"Y Fu","year":"2016","unstructured":"Fu Y, Zhao J, Atagi Y, Nielsen HM, Liu CC, Zheng H, et al. Apolipoprotein E lipoprotein particles inhibit amyloid-\u03b2 uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener. 2016;11(1):37.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"688_CR51","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","volume":"129","author":"M Tachibana","year":"2019","unstructured":"Tachibana M, Holm ML, Liu CC, Shinohara M, Aikawa T, Oue H, et al. APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1. J Clin Invest. 2019;129(3):1272\u20137.","journal-title":"J Clin Invest"},{"issue":"3","key":"688_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997;17(3):263\u20134.","journal-title":"Nat Genet"},{"issue":"12","key":"688_CR53","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim J, Eltorai AE, Jiang H, Liao F, Verghese PB, Kim J, et al. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A\u03b2 amyloidosis. J Exp Med. 2012;209(12):2149\u201356.","journal-title":"J Exp Med"},{"issue":"21","key":"688_CR54","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.1523\/JNEUROSCI.23-21-07889.2003","volume":"23","author":"JD Fryer","year":"2003","unstructured":"Fryer JD, Taylor JW, DeMattos RB, Bales KR, Paul SM, Parsadanian M, et al. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J Neurosci. 2003;23(21):7889\u201396.","journal-title":"J Neurosci"},{"issue":"5","key":"688_CR55","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.ajpath.2013.01.034","volume":"182","author":"MA Kuszczyk","year":"2013","unstructured":"Kuszczyk MA, Sanchez S, Pankiewicz J, Kim J, Duszczyk M, Guridi M, et al. Blocking the interaction between apolipoprotein E and A\u03b2 reduces intraneuronal accumulation of A\u03b2 and inhibits synaptic degeneration. Am J Pathol. 2013;182(5):1750\u201368.","journal-title":"Am J Pathol"},{"issue":"2","key":"688_CR56","first-page":"195","volume":"67","author":"MI Kamboh","year":"1995","unstructured":"Kamboh MI. Apolipoprotein E polymorphism and susceptibility to Alzheimer\u2019s disease. Hum Biol. 1995;67(2):195\u2013215.","journal-title":"Hum Biol"},{"issue":"6","key":"688_CR57","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","volume":"10","author":"DM Michaelson","year":"2014","unstructured":"Michaelson DM. APOE \u03b54: the most prevalent yet understudied risk factor for Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(6):861\u20138.","journal-title":"Alzheimers Dement"},{"key":"688_CR58","first-page":"75","volume":"2","author":"JE Pankiewicz","year":"2014","unstructured":"Pankiewicz JE, Guridi M, Kim J, Asuni AA, Sanchez S, Sullivan PM, et al. Blocking the apoE\/A\u03b2 interaction ameliorates A\u03b2-related pathology in APOE \u03b52 and \u03b54 targeted replacement Alzheimer model mice. Acta Neuropathol Commun. 2014;2:75.","journal-title":"Acta Neuropathol Commun."},{"issue":"3","key":"688_CR59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, Zhou B, Wernig M, S\u00fcdhof TC. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion. Cell. 2017;168(3):427\u201341 e21.","journal-title":"Cell"},{"issue":"5","key":"688_CR60","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA. Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in Alzheimer disease. Ann Neurol. 2019;85(5):726\u201339.","journal-title":"Ann Neurol"},{"issue":"7673","key":"688_CR61","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549(7673):523\u20137.","journal-title":"Nature."},{"issue":"2","key":"688_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/cells8020182","volume":"8","author":"BC Farmer","year":"2019","unstructured":"Farmer BC, Kluemper J, Johnson LA. Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation. Cells. 2019;8(2):182.","journal-title":"Cells."},{"key":"688_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-981-13-3540-2_5","volume":"1128","author":"M Shinohara","year":"2019","unstructured":"Shinohara M, Sato N. The roles of Apolipoprotein E, lipids, and glucose in the pathogenesis of Alzheimer's disease. Adv Exp Med Biol. 2019;1128:85\u2013101.","journal-title":"Adv Exp Med Biol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T20:38:30Z","timestamp":1633120710000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00688-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.19388\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19388\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures in this study were performed according to the protocol reviewed and approved by the Nanjing Medical University Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}